Registered Nurse
About the job
- Graduate of a Bachelor of Science in Nursing program.
- Hold an active PHRN license.
- Have at least 2 years of hospital experience.
- Be willing to work onsite.
- Assess and interpret customer needs and requirements.
- Identify solutions to non-standard requests and problems.
- Solve moderately complex problems and conduct moderately complex analyses.
- Work with minimal guidance and seek guidance only on the most complex tasks.
- Translate concepts into practice.
- Provide explanations and information to others on difficult issues.
- Coach, provide feedback, and guide others.
- Act as a resource for others with less experience.
- Use a basic, structured, standard approach to work.
- Comply with the employment contract, company policies and procedures, and directives, including possible changes to work locations, teams, shifts, flexibility and work arrangements.
Optum is a global organization that delivers care, aided by technology to help millions of people live healthier lives. The work you do with our team will directly improve health outcomes by connecting people with the care, pharmacy benefits, data and resources they need to feel their best. Here, you will find a culture guided by inclusion, talented peers, comprehensive benefits and career development opportunities. Come make an impact on the communities we serve as you help us advance health optimization on a global scale. Join us to start Caring. Connecting. Growing together.
Primary Responsibilities\:
- Assesses and interprets customer needs and requirements
- Identifies solutions to non-standard requests and problems
- Solves moderately complex problems and/or conducts moderately complex analyses
- Works with minimal guidance; seeks guidance on only the most complex tasks
- Translates concepts into practice
- Provides explanations and information to others on difficult issues
- Coaches, provides feedback, and guides others
- Acts as a resource for others with less experience
- Basic, structured, standard approach to work
- Comply with the terms and conditions of the employment contract, company policies and procedures, and any and all directives (such as, but not limited to, transfer and/or re-assignment to different work locations, change in teams and/or work shifts, policies in regard to flexibility of work benefits and/or work environment, alternative work arrangements, and other decisions that may arise due to the changing business environment). The Company may adopt, vary or rescind these policies and directives in its absolute discretion and without any limitation (implied or otherwise) on its ability to do so
Optum is a global organization that delivers care, aided by technology to help millions of people live healthier lives. The work you do with our team will directly improve health outcomes by connecting people with the care, pharmacy benefits, data and resources they need to feel their best. Here, you will find a culture guided by inclusion, talented peers, comprehensive benefits and career development opportunities. Come make an impact on the communities we serve as you help us advance health optimization on a global scale. Join us to start Caring. Connecting. Growing together.
Primary Responsibilities\:
- Assesses and interprets customer needs and requirements
- Identifies solutions to non-standard requests and problems
- Solves moderately complex problems and/or conducts moderately complex analyses
- Works with minimal guidance; seeks guidance on only the most complex tasks
- Translates concepts into practice
- Provides explanations and information to others on difficult issues
- Coaches, provides feedback, and guides others
- Acts as a resource for others with less experience
- Basic, structured, standard approach to work
- Comply with the terms and conditions of the employment contract, company policies and procedures, and any and all directives (such as, but not limited to, transfer and/or re-assignment to different work locations, change in teams and/or work shifts, policies in regard to flexibility of work benefits and/or work environment, alternative work arrangements, and other decisions that may arise due to the changing business environment). The Company may adopt, vary or rescind these policies and directives in its absolute discretion and without any limitation (implied or otherwise) on its ability to do so
Required Qualifications\:
- Graduate of Bachelor Science in Nursing
- PHRN with active license
- 2+ years of hospital experience
- Willing to work onsite
At UnitedHealth Group, our mission is to help people live healthier lives and make the health system work better for everyone. We believe everyone - of every race, gender, sexuality, age, location and income - deserves the opportunity to live their healthiest life. Today, however, there are still far too many barriers to good health which are disproportionately experienced by people of color, historically marginalized groups and those with lower incomes. We are committed to mitigating our impact on the environment and enabling and delivering equitable care that addresses health disparities and improves health outcomes - an enterprise priority reflected in our mission.
Optum is a drug-free workplace. © 2026 Optum Global Solutions (Philippines) Inc. All rights reserved.
Required Qualifications\:
- Graduate of Bachelor Science in Nursing
- PHRN with active license
- 2+ years of hospital experience
- Willing to work onsite
At UnitedHealth Group, our mission is to help people live healthier lives and make the health system work better for everyone. We believe everyone - of every race, gender, sexuality, age, location and income - deserves the opportunity to live their healthiest life. Today, however, there are still far too many barriers to good health which are disproportionately experienced by people of color, historically marginalized groups and those with lower incomes. We are committed to mitigating our impact on the environment and enabling and delivering equitable care that addresses health disparities and improves health outcomes - an enterprise priority reflected in our mission.
Optum is a drug-free workplace. © 2026 Optum Global Solutions (Philippines) Inc. All rights reserved.
Tell us about a friend who might be interested in this job. All privacy rights will be protected.About the company
UnitedHealth Group runs health insurance and clinical care services for individuals, employers and government programs through UnitedHealthcare and Optum. UnitedHealthcare sells medical benefits for working people, retirees and people covered by public programs, including Medicare and Medicaid. Optum operates medical practices, manages prescription drug benefits and builds software that helps healthcare organizations handle clinical and administrative work. The group earns revenue from insurance premiums, care contracts, pharmacy products and service fees. UnitedHealth Group was incorporated in 1977 and is headquartered in Eden Prairie, Minnesota.
Company Size
10,001+
Company Stage
IPO
Headquarters
Eden Prairie, Minnesota
Founded
1977
Get referred to UnitedHealth Group
See people who can refer or advise you
Simplify's Take
What believers are saying
- UnitedHealth generates cash for reinvestment: July 2026 results reported $11.1 billion in second-quarter operating cash flow.
- Career paths span care and technology: UnitedHealth lists clinical, data, business operations and support career areas.
- Optum Insight diversifies buyers: its software services target health plans, providers, governments and life sciences companies.
What critics are saying
- UnitedHealth restructuring affects jobs: January 2026 results disclosed $746 million for late-2025 workforce cuts and property consolidation.
- Optum carries unprofitable contracts: January 2026 results disclosed $623 million reserved for relationships it cannot exit during 2026.
- UnitedHealthcare absorbs care-cost increases: insurance premiums typically stay fixed per person for a year.
What makes UnitedHealth Group unique
- UnitedHealth connects care spending to finance: Optum Financial runs health accounts and payments to medical providers.
- UnitedHealth combines technology with clinical scale: its 2025 workforce included nearly 165,000 clinical professionals.
- Optum Rx promises predictable drug spending: Clear Trend Guarantee combines pharmacy cost guarantees into one per-member price.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Flexible Work Hours
Growth & Insights and Company News
6 month growth
-8%1 year growth
-6%2 year growth
-6%Promising healthcare stocks to add to your watchlist - october 24th. Moderna, Eli Lilly and Company, and UnitedHealth Group are the three Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of publicly traded companies involved in the healthcare industry, including pharmaceuticals, biotechnology, medical devices, healthcare services, and health insurance. Investors may consider them for their growth potential, defensive characteristics, and exposure to healthcare demand, though they remain subject to market, regulatory, competitive, and clinical risks. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days. Moderna (MRNA). Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. Discover more Stock trading guide Share market analysis Financial news subscription Eli Lilly and Company (LLY). Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. UnitedHealth Group (UNH). UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
UnitedHealth Group Incorporated $UNH stock holdings raised by Robeco Institutional Asset Management B.V. October 21, 2026 Robeco Institutional Asset Management B.V. lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 30.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 973,563 shares of the healthcare conglomerate's stock after acquiring an additional 224,397 shares during the period. Robeco Institutional Asset Management B.V. owned approximately 0.11% of UnitedHealth Group worth $357,376,000 as of its most recent filing with the Securities & Exchange Commission. Several other hedge funds and other institutional investors have also added to or reduced their stakes in UNH. Corient Private Wealth LP purchased a new stake in UnitedHealth Group during the 2nd quarter valued at $245,516,000. Legal & General Group Plc purchased a new position in shares of UnitedHealth Group in the second quarter worth $2,444,928,000. Jupiter Topco LLC bought a new position in shares of UnitedHealth Group during the second quarter valued at $2,019,844,000. BlackRock Inc. boosted its position in shares of UnitedHealth Group by 4.6% during the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock valued at $31,946,594,000 after buying an additional 3,395,530 shares during the last quarter. Finally, Canada Pension Plan Investment Board bought a new stake in UnitedHealth Group in the 2nd quarter worth about $971,757,000. 87.86% of the stock is owned by institutional investors. Key UnitedHealth Group news. Here are the key news stories impacting UnitedHealth Group this week: * A Seeking Alpha analyst initiated coverage with a Strong Buy rating and a $533 price target, citing margin recovery, improved Optum Health contracts and AI-related efficiencies as potential drivers of double-digit EPS growth through 2028. The analyst also viewed UNH's valuation as discounted relative to the healthcare sector. * UnitedHealth was selected as a CNBC "Final Trades" stock after its better-than-expected quarterly results, adding to favorable short-term investor sentiment. * Analysts and investors are reassessing UNH after the earnings beat and raised outlook, while commentary suggests the stock's recent momentum reflects renewed confidence in medical-cost trends and operational execution. * UnitedHealth's results have renewed interest in healthcare ETFs with UNH exposure, although diversification may reduce the impact of company-specific gains and limit direct upside. * A competing analyst downgraded UNH from Strong Buy to Buy, arguing that the shares may already reflect much of the recovery at roughly 20 times forward earnings. Valuation, medical-cost pressure and execution risks remain concerns. * Reports of rising healthcare costs, reduced services and higher prescription-drug prices for older Americans could increase political scrutiny and pressure insurers' affordability and retention metrics. * Declining individual-market enrollment and reports that millions of seniors may lose Medicare Advantage plans highlight regulatory, membership and pricing risks for the broader insurance industry, including UNH. Insider activity at UnitedHealth Group. In other news, CEO Patrick Conway sold 1,169 shares of the company's stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. This represents a 7.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.19% of the stock is owned by company insiders. UnitedHealth Group price performance. Shares of NYSE:UNH opened at $419.70 on Wednesday. The company has a quick ratio of 0.78, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $376.72 billion, a PE ratio of 23.97, a price-to-earnings-growth ratio of 1.47 and a beta of 0.60. The firm's 50 day moving average price is $387.40 and its 200-day moving average price is $387.49. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62. UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The company had revenue of $112.70 billion during the quarter, compared to analyst estimates of $111.31 billion. During the same period in the previous year, the business posted $2.59 earnings per share. The firm's quarterly revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 20.64 EPS for the current year. UnitedHealth Group announces dividend. The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were given a dividend of $2.32 per share. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.2%. UnitedHealth Group's payout ratio is presently 53.00%. Analysts set new price targets. Several equities analysts have issued reports on the stock. Zacks Research cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Monday, September 14th. JPMorgan Chase & Co. lifted their price target on shares of UnitedHealth Group from $516.00 to $524.00 and gave the stock an "overweight" rating in a research note on Friday, October 16th. Bank of America reissued a "buy" rating and set a $450.00 price objective on shares of UnitedHealth Group in a report on Monday, July 20th. Mizuho increased their price objective on shares of UnitedHealth Group from $470.00 to $493.00 and gave the company an "outperform" rating in a research report on Monday, July 20th. Finally, BMO Capital Markets set a $512.00 target price on shares of UnitedHealth Group in a report on Tuesday, July 21st. Twenty research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $463.57. About UnitedHealth Group. UnitedHealth Group Incorporated NYSE: UNH is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States. The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid. Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report). This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider UnitedHealth Group, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list. While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public. Continue following MarketBeat
US insurers including UnitedHealth and Humana are cutting benefits for older clients and raising prescription drug costs for 2027, weeks before the midterm elections. Both insurers scrapped hundreds of plans and tightened coverage as older voters began choosing their plans. UnitedHealth and Humana raised maximum out-of-pocket costs by 11% and 8% respectively, according to investment bank Leerink. Both raised prescription drug coverage costs by about 30%. The changes affect 35 million Americans on Medicare Advantage plans, and the two firms hold about 46% of that market. The changes should help insurers' profits. UnitedHealth's healthcare division operating margin rose to 3.3% from 2.1% a year earlier, and Humana's shares are up 57% this year.
Kaiser tops U.S. News' best Medicare Advantage list. Kaiser Permanente leads the 2027 list of best Medicare Advantage companies from U.S. News & World Report, with an overall rating of 4.4 out of 5. UnitedHealthcare, Humana, Aetna and Devoted Health round out the top tier, each rated 3.8, according to the ratings published Oct. 14. The ratings matter because they arrive at the start of Medicare's annual open enrollment, which runs Oct. 15 through Dec. 7, when beneficiaries compare plans. They also offer a second, independently weighted view of insurer quality alongside CMS's Star Ratings released earlier in October. The best Medicare Advantage companies for 2027. U.S. News named five companies as best overall for Medicare Advantage: * Kaiser Permanente: 4.4 * UnitedHealthcare: 3.8 * Humana: 3.8 * Aetna: 3.8 * Devoted Health: 3.8 Three of the five, Aetna, Devoted Health and UnitedHealth Group, were also named best Medicare Advantage companies in the 2026 edition, according to U.S. News' 2026 announcement. Kaiser Permanente and Humana are new to the top list for 2027. U.S. News also recognized top companies in three consumer-focused categories: highest satisfaction, screening and prevention, and care continuity. How U.S. News rated insurers. U.S. News rates Medicare Advantage contracts on a five-point scale, assigning its own weights to more than 30 quality measures published by CMS. Those weights do not necessarily match the ones CMS uses for Star Ratings. U.S. News then calculates an enrollment-adjusted average rating for each company. To be named among the best, a company needed an overall rating of at least 3.8 after rounding and had to serve at least 1,000 beneficiaries as of December 2025 in each of 10 or more states or territories where it still offers coverage for 2027. The ratings covered both standalone Medicare Advantage contracts and those that include Part D drug coverage. Part D leaders unchanged. For standalone prescription drug coverage, the same two companies earned best overall recognition in both 2026 and 2027. Humana scored 3.8 and Centene scored 3.5 for 2027, according to U.S. News. To qualify as a top Part D company, an insurer needed at least 1,000 Part D beneficiaries in each of at least 10 jurisdictions where it still offers 2027 coverage, and an enrollment-weighted average rating of at least 3.5 after rounding. How the ratings compare with CMS stars. The U.S. News results broadly track this year's CMS Star Ratings, which showed Humana rebounding sharply, with 95 percent of its Medicare Advantage members in plans rated 4 stars or higher, up from about 20 percent. Aetna and UnitedHealthcare saw their share of members in 4-star-or-better plans decline, though both still met U.S. News' threshold. Because U.S. News applies its own weighting and requires a presence in at least 10 states, its list highlights larger multistate carriers. Strong regional plans may appear instead in U.S. News' state-by-state rankings. Those state-level ratings recognize a wider field. In the 2026 edition, fewer than one-third of Medicare Advantage insurers nationwide earned a best insurance company designation in at least one state, according to Geisinger Health Plan, which was named a best company in Pennsylvania that year. Regional and provider-owned plans such as Geisinger's often compete closely with national carriers in their home markets even when they fall short of the 10-state requirement for the national list, giving beneficiaries more top-rated options to compare locally. What it means for beneficiaries and plans. For beneficiaries, the ratings are one input among several. Plan networks, drug formularies, premiums and out-of-pocket costs vary widely by county, and a highly rated company may not offer the best plan in a given area. For insurers, appearing among the best Medicare Advantage companies can be a marketing advantage during open enrollment. Unlike CMS Star Ratings, the U.S. News ratings do not affect federal quality bonus payments, but they shape how consumers and brokers view plan quality as enrollment decisions are made.
UnitedHealth targets No Surprises Act arbitration wins as Congress weighs ending IDR. UnitedHealth says No Surprises Act arbitration awards are its biggest cost pressure. What practices that use IDR should document now. UnitedHealth Group told Wall Street on Oct. 13 that No Surprises Act arbitration awards are the biggest cost problem in its employer business and accused a small number of clinician groups of abusing the dispute process. Practices that depend on those wins should expect the country's largest payer to fight harder to shrink them. Physician groups have heard the argument before. "If the payers are hiding behind the more egregious cases, I don't think they are really addressing the main issue, which is that providers still prevail the vast majority of the time," Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association (MGMA), told Physicians Practice in. Gilberg acknowledged a few outrageous cases and some profit-driven ownership arrangements but called them "the exception to the rule." On the company's third-quarter earnings call, executives said arbitration awards can approach nearly 6 percent of total medical spend in some regions, with some awards running 10 to 11 times what Medicare would pay, according to. They said UnitedHealth will keep working with policymakers and regulators to make sure the law works as Congress intended. The warning came in a strong quarter. UnitedHealth reported $4.1 billion in profit, up from $2.3 billion a year earlier, and a medical loss ratio of 88.4 percent, down from 89.9 percent,. But spending in employer-sponsored plans ran high for a second straight quarter, and executives pointed to arbitration payouts, pricier specialty drugs and providers billing more aggressively,. They put commercial cost trend above 11 percent and pointed to rising cost intensity from clinicians. Why the timing matters. UnitedHealth is making its case while Congress debates whether arbitration should exist at all. Rep. Frank Pallone Jr. (D-N.J.), ranking member of the House Energy and Commerce Committee, introduced the Lower Premiums, Faster Payments Act on Oct. 8. According to, it would end open negotiation and IDR for services furnished on or after Jan. 1, 2028, make the qualifying payment amount (QPA) the out-of-network rate, require payment within 30 days and bar judicial review of how the QPA is calculated. The same analysis notes the bill's near-term prospects look limited with Pallone in the minority. Still, the largest payer publicly tying arbitration to employer premiums hands lawmakers and regulators a ready talking point. For now, the numbers favor providers. They won 88 percent of resolved disputes in the first quarter of 2024 and 83 percent in the second, and the median winning provider offer ran 383 percent to 447 percent of the QPA, according to. Five organizations accounted for 63 percent of resolved cases, the kind of concentration UnitedHealth is pointing to. Volume keeps climbing. Parties started more than 2.1 million disputes from Jan. 1 through July 31, 2026, according to. Of the 671,465 disputes closed in June and July, 98,398, or nearly 15 percent, were found ineligible. What it means for practices. For an independent group that relies on arbitration, the cost intensity complaint is the part to watch. When a payer names clinician billing as a driver of employer costs, practices can expect closer scrutiny of coding levels, more downcoding and more records requests on out-of-network claims. The best defense is a clean file on every dispute. list what certified IDR entities look for: the complete remittance or denial notice with its codes, a full explanation of benefits, the claim number and the QPA. Practices should also keep the emails or portal records showing they started the 30-business-day open negotiation period, because they must produce them if the payer says negotiation never happened. CMS flags incorrect batching as one of the most common mistakes. The raises the bar further. Open negotiation notices now go through the federal portal, each party pays a $15 administrative fee per dispute, batched disputes are capped at 50 line items and parties get five business days to answer an IDR entity's request for more information. Winning is only half the job. Gilberg said in June that providers prevail more than 80 percent of the time "only to receive no payment," and called for "more accountability so that when a provider prevails in the IDR process, they actually get paid in a timely manner." The courts have not filled that gap. On Sept. 17, the 2nd U.S. Circuit Court of Appeals ruled that a provider could not sue Cigna to collect more than $3 million in unpaid awards and pointed it to federal agencies and states for enforcement,. UnitedHealth did not say what it will ask regulators for. Pallone's bill would not take effect before 2028 even if it passed, so arbitration remains the path for today's disputes, and practices that document every step will be in the strongest position however the policy fight ends.